Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) had its price target lowered by HC Wainwright from $18.50 to $14.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 142.63% from the company’s previous close.
Several other analysts have also weighed in on the company. Stifel Nicolaus cut their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a report on Monday. Weiss Ratings began coverage on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, February 17th. They issued a “sell (d-)” rating for the company. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.00.
Read Our Latest Stock Report on SENS
Senseonics Holdings, Inc. Common Stock Stock Performance
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 111.78% and a negative net margin of 213.87%.The business had revenue of $11.71 million during the quarter. On average, equities research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.83 EPS for the current year.
Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock
In other news, Director Douglas A. Roeder acquired 17,500 shares of the business’s stock in a transaction dated Friday, March 13th. The stock was acquired at an average price of $5.73 per share, for a total transaction of $100,275.00. Following the completion of the acquisition, the director directly owned 119,731 shares in the company, valued at $686,058.63. This represents a 17.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO Timothy T. Goodnow acquired 17,225 shares of the business’s stock in a transaction dated Friday, March 13th. The stock was purchased at an average price of $5.79 per share, with a total value of $99,732.75. Following the acquisition, the chief executive officer owned 651,243 shares of the company’s stock, valued at approximately $3,770,696.97. This trade represents a 2.72% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 4.70% of the company’s stock.
Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock
Hedge funds have recently modified their holdings of the stock. Jain Global LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at $88,000. State of Wyoming lifted its holdings in shares of Senseonics Holdings, Inc. Common Stock by 202.6% during the second quarter. State of Wyoming now owns 182,989 shares of the company’s stock valued at $87,000 after purchasing an additional 122,510 shares during the last quarter. Hudson Bay Capital Management LP purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at $85,000. Beck Mack & Oliver LLC lifted its holdings in shares of Senseonics Holdings, Inc. Common Stock by 16.5% during the second quarter. Beck Mack & Oliver LLC now owns 176,950 shares of the company’s stock valued at $84,000 after purchasing an additional 25,000 shares during the last quarter. Finally, Captrust Financial Advisors purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at $77,000. 12.36% of the stock is owned by hedge funds and other institutional investors.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Featured Stories
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
